Wheatgrass (Young Wheat Leaf)

Triticum aestivum
Evidence Level
Limited
5 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Wheatgrass is the young leaf of the common wheat plant, Triticum aestivum, cut shortly after sprouting and sold as fresh juice shots, frozen juice, powder and tablets. It is marketed as a superfood for its chlorophyll, vitamins and antioxidant pigments, and it does contain those compounds, in amounts that vary with growing conditions and drying method. The clinical record is far thinner than the marketing: a handful of small studies, one placebo-controlled trial of 23 people with ulcerative colitis, and blood transfusion studies whose early positive results did not hold up in a randomized comparison. The popular claim that chlorophyll turns into blood has no support.

Studied Dose Fresh juice 60-100 mL/day; tablets of dried powder, 12/day of unstated strength, in one trial; no standardized dose
Active Compound Chlorophyll, flavonoids, vitamins C and E, beta-carotene

Benefits

Antioxidant pigments and vitamins in the fresh grass

Young wheat leaves contain chlorophyll, flavonoids, vitamins C and E and beta-carotene, and their extracts show antioxidant activity in laboratory assays. Content varies with growing conditions and processing: freeze drying kept the most chlorophyll and antioxidant activity, while oven drying lost vitamin C and beta-carotene. A test-tube reading does not show an effect inside the body.

Oxidative stress markers: thin human data

Direct human evidence is limited to a short letter, with no abstract to check its methods, reporting that wheatgrass lowered oxidative stress in healthy people in a comparison with spirulina, and a two-week study of 14 young women drinking wheat sprout juice with no control group. That makes the antioxidant idea plausible, not demonstrated.

Gut lining support: one small trial in ulcerative colitis

In a double-blind trial, 23 people with active distal ulcerative colitis drank 100 mL of wheatgrass juice or a matching placebo daily for a month. The juice group had a lower overall disease activity score and less rectal bleeding. Only 19 people had complete data, and we found no confirmatory trial since. It does not replace prescribed colitis care.

Studied alongside chemotherapy for blood counts

In a pilot study of 60 patients with breast cancer, those drinking 60 mL of juice daily through three chemotherapy cycles had fewer dose reductions, early stops or growth-factor starts than matched controls, 5 such events versus 15. There was no placebo, and six patients quit the juice because it worsened nausea. Any use during cancer treatment belongs with the oncology team.

Thalassemia transfusion studies point in different directions

An early pilot in beta thalassemia major, comparing time on home-grown juice with the year before, found transfusion needs fell by more than a quarter in 8 of 16 patients. Later uncontrolled series split, and the largest, 53 patients on wheatgrass tablets, saw no fall over a year. When 69 children were randomized to tablets or no wheatgrass for 18 months, transfusion numbers and blood needed did not differ between groups.

Mechanism of action

1

Chlorophyll does not become hemoglobin

Chlorophyll and the heme in hemoglobin share a ring-shaped porphyrin core, but chlorophyll holds magnesium where heme holds iron, and the body does not convert one into the other. The popular liquid-blood idea therefore has no mechanism behind it; any effect on blood counts would have to come through some other route.

2

Dietary antioxidants and processing losses

Flavonoids, phenolic compounds, vitamin C, vitamin E and carotenoids can neutralize reactive oxygen species in laboratory tests. Heat and drying degrade vitamin C and carotenoids, so freeze-dried powder keeps more than oven-dried material. Radical scavenging in a test tube does not predict what survives digestion and absorption.

3

Possible local action in the colon

In the colitis trial, electrochemical testing of the fresh juice gave a strong signal that the authors took to reflect four groups of compounds with antioxidant behavior. That suggests, but does not show, that these compounds could act locally on an irritated colon lining. The trial measured symptoms and endoscopic findings, not mechanism, so this remains a hypothesis.

Clinical trials

1
Wheatgrass Juice in Active Distal Ulcerative Colitis
PubMed

Randomized, double-blind, placebo-controlled trial of 100 mL wheatgrass juice daily for one month (Ben-Arye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E 2002, Scand J Gastroenterol 37(4):444-9, PMID 11989836).

23 patients with clinically and sigmoidoscopically confirmed active distal ulcerative colitis, recruited through one hospital gastroenterology unit and three coordinating centers in Israel; 21 completed and 19 had full data.

Wheatgrass juice was associated with significant reductions in the overall disease activity index (P=0.031) and in the severity of rectal bleeding (P=0.025), with no serious side effects. The authors judged it effective and safe as single or add-on therapy, but with 19 analyzable patients and no replication, this is a signal rather than a proven treatment.

2
Wheatgrass Juice and Transfusion Needs in Thalassemia Major - Pilot
PubMed

Self-controlled pilot study comparing the period on daily wheatgrass juice with the preceding year (Marawaha RK, Bansal D, Kaur S, Trehan A 2004, Indian Pediatr 41(7):716-20, PMID 15297687).

16 analyzed patients with transfusion-dependent beta thalassemia major whose families grew the grass at home; about 100 mL of juice daily.

Packed red cell requirement fell by more than 25% in 8 of 16 patients, and by more than 40% in 3 of them, with no perceptible adverse effects. Each patient served as his own control and there was no comparison group, so other changes over time cannot be ruled out.

3
Randomized Open-Label Trial in Thalassemic Children
PubMed

Randomized, prospective, open-label study of wheatgrass tablets versus no wheatgrass for 18 months, with both groups receiving regular transfusions and folic acid (Mutha AS, Shah KU, Kinikar AA, Ghongane BB 2018, Cureus 10(3):e2306, PMID 29755902).

69 children with thalassemia on regular transfusion, 45 allocated to wheatgrass and 24 to control; 12 and 3 respectively did not complete the study.

The average number of transfusions and the blood transfusion requirement did not differ between groups, and serum ferritin did not differ between groups, though it rose from baseline only in the control group. Fetal hemoglobin rose and quality of life improved within the wheatgrass group. The groups differed in age, and one child stopped the tablets after a rash. The authors called wheatgrass promising while conceding it did not reduce transfusion needs.

4
Wheatgrass Juice During Breast Cancer Chemotherapy - Pilot
PubMed

Prospective matched-control pilot study of 60 mL wheatgrass juice daily during the first three cycles of FAC chemotherapy (Bar-Sela G, Tsalic M, Fried G, Goldberg H 2007, Nutr Cancer 58(1):43-8, PMID 17571966).

60 patients with breast carcinoma assigned to juice plus regular supportive care or regular supportive care alone.

Censoring events, defined as premature termination, dose reduction or starting G-CSF or epoetin, occurred 5 times in the juice arm and 15 times in the control arm (P=0.01); 11 of the 15 were hematological. No reduction in chemotherapy response was seen. Worsening nausea led six patients to stop the juice. The authors called for a phase III trial to confirm the result.

5
Wheat Sprout Juice and Bisphenol A in Young Women
PubMed

Two-week uncontrolled intervention with 100 mL/day of wheat sprout juice (Yi B, Kasai H, Lee HS, Kang Y, Park JY, Yang M 2011, Mutat Res 724(1-2):64-8, PMID 21736952).

14 young women, mean age 24.4 years.

Urinary bisphenol A fell steadily during the intervention (p=0.02), and BPA exposure tracked with the oxidative marker malondialdehyde (p=0.03). The abstract does not report that the juice itself lowered oxidative stress markers, and with no control group the fall in BPA cannot be attributed to the juice with confidence.

Side effects and drug interactions

Common Potential side effects

Nausea is the main reported complaint; in one chemotherapy study six patients stopped the juice because it made nausea worse.
Tolerability varies by form, and the strong grassy taste of fresh juice puts some people off.
Raw, unpasteurized juice and home-grown grass can carry mold or bacteria; people with weakened immunity should avoid fresh juice.
Grass is cut before the grain forms, but seed contamination is possible; people with coeliac disease or wheat allergy should avoid it unless the product is certified gluten-free.
Allergic reactions are possible in people sensitive to wheat or grasses; one child in a thalassemia trial stopped the tablets after a body rash.
Safety in pregnancy and breastfeeding has not been studied.
Not a substitute for transfusion, iron chelation or prescribed colitis treatment.

Important Drug interactions

Warfarin and other vitamin K antagonists: like other green leaf products, wheatgrass may contain vitamin K and content is rarely labeled; keep intake steady and tell the prescriber.
Chemotherapy: one small study saw no reduction in chemotherapy response, but raw juice is a food-safety risk when white cell counts are low; clear any use with the oncology team.
Iron chelators such as deferasirox or deferiprone: wheatgrass was studied only as an add-on in thalassemia and must not replace prescribed chelation.
Immunosuppressants such as tacrolimus, azathioprine or corticosteroids: avoid raw, unpasteurized juice because of infection risk.
Mesalamine and other ulcerative colitis medicines: no interaction study exists; do not stop or reduce prescribed therapy in favor of wheatgrass.

Frequently asked questions about Wheatgrass (Young Wheat Leaf)

What is Wheatgrass?

Wheatgrass is the young leaf of the common wheat plant, Triticum aestivum, cut shortly after sprouting and sold as fresh juice shots, frozen juice, powder and tablets.

What is Wheatgrass used for?

Wheatgrass is researched primarily for Antioxidant and Gut Health. Young wheat leaves contain chlorophyll, flavonoids, vitamins C and E and beta-carotene, and their extracts show antioxidant activity in laboratory assays.

What is the recommended dosage of Wheatgrass?

The clinically studied dose is Fresh juice 60-100 mL/day; tablets of dried powder, 12/day of unstated strength, in one trial; no standardized dose Always follow the product label and check with a healthcare provider for personal advice.

Is Wheatgrass safe, and does it have side effects?

For most healthy adults, Wheatgrass is well tolerated at studied doses. Reported effects can include: Nausea is the main reported complaint; in one chemotherapy study six patients stopped the juice because it made nausea worse. Tolerability varies by form, and the strong grassy taste of fresh juice puts some people off. It may also interact with some medications. Wheatgrass is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Wheatgrass interact with any medications?

Possible interactions include: Warfarin and other vitamin K antagonists: like other green leaf products, wheatgrass may contain vitamin K and content is rarely labeled; keep intake steady and tell the prescriber. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Wheatgrass?

NutraSmarts rates the evidence for Wheatgrass as Limited (2 out of 5). It is backed by 5 clinical trials and 9 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(9 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Bar-Sela G, Cohen M, Ben-Arye E, Epelbaum R. The Medical Use of Wheatgrass: Review of the Gap Between Basic and Clinical Applications. Mini Rev Med Chem. 2015;15(12):1002-10..PubMedUsed to support: Narrative review, written by researchers who ran several of the wheatgrass trials, listing chlorophyll, flavonoids and vitamins C and E among its components and noting that composition varies with production and growing conditions. It concluded that all clinical trials were small with methodological problems and that larger studies are needed before public recommendations can be made.
  2. Devi CB, Bains K, Kaur H. Effect of drying procedures on nutritional composition, bioactive compounds and antioxidant activity of wheatgrass (Triticum aestivum L). J Food Sci Technol. 2019;56(1):491-496..PubMedUsed to support: Laboratory comparison of shade, oven and freeze drying: oven-dried wheatgrass had significantly less vitamin C and beta-carotene, and freeze drying preserved the most chlorophyll, flavonoids and antioxidant activity. Supports the content and processing statements; no human participants.
  3. Shyam R, Singh SN, Vats P, Singh VK, Bajaj R, Singh SB, Banerjee PK. Wheat grass supplementation decreases oxidative stress in healthy subjects: a comparative study with spirulina. J Altern Complement Med. 2007;13(8):789-91..PubMedUsed to support: A short letter whose title reports lower oxidative stress in healthy people given wheatgrass, in a comparison with spirulina. Its PubMed record has no abstract, so the dose, group sizes and markers could not be checked; it is cited as the only direct human antioxidant report, not as strong evidence.
  4. Yi B, Kasai H, Lee HS, Kang Y, Park JY, Yang M. Inhibition by wheat sprout (Triticum aestivum) juice of bisphenol A-induced oxidative stress in young women. Mutat Res. 2011;724(1-2):64-8..PubMedUsed to support: Two-week uncontrolled study in 14 young women drinking 100 mL/day of wheat sprout juice: urinary bisphenol A fell during the intervention and BPA tracked with malondialdehyde, but the abstract does not show that the juice lowered oxidative stress markers.
  5. Ben-Arye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol. 2002;37(4):444-9..PubMedUsed to support: The only placebo-controlled wheatgrass trial on this page: 23 patients with active distal ulcerative colitis, 100 mL juice daily for one month, with lower disease activity (P=0.031) and rectal bleeding (P=0.025) in the 19 with full data. Also the source of the electrochemical finding of antioxidant compound groups in fresh juice.
  6. Bar-Sela G, Tsalic M, Fried G, Goldberg H. Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study. Nutr Cancer. 2007;58(1):43-8..PubMedUsed to support: Matched-control pilot in 60 breast cancer patients on FAC chemotherapy: 5 versus 15 censoring events (P=0.01), no reduction in chemotherapy response, and six patients stopping the juice for worsening nausea. The authors said a phase III study was needed.
  7. Marawaha RK, Bansal D, Kaur S, Trehan A. Wheat grass juice reduces transfusion requirement in patients with thalassemia major: a pilot study. Indian Pediatr. 2004;41(7):716-20..PubMedUsed to support: The self-controlled pilot behind the thalassemia interest: transfusion requirement fell by more than 25% in 8 of 16 patients drinking about 100 mL of home-grown juice daily, compared with the preceding year, with no comparison group.
  8. Mutha AS, Shah KU, Kinikar AA, Ghongane BB. Efficacy and Safety of Wheat Grass in Thalassemic Children on Regular Blood Transfusion. Cureus. 2018;10(3):e2306..PubMedUsed to support: Randomized open-label study of 69 children over 18 months: no difference between wheatgrass and control groups in number of transfusions or blood transfusion requirement, and no significant between-group difference in serum ferritin. The randomized counterweight to the earlier self-controlled pilot.
  9. Choudhary DR, Naithani R, Panigrahi I, Kumar R, Mahapatra M, Pati HP, Saxena R, Choudhry VP. Effect of wheat grass therapy on transfusion requirement in beta-thalassemia major. Indian J Pediatr. 2009;76(4):375-6..PubMedUsed to support: Uncontrolled before-and-after study in 53 patients with beta thalassemia major (median age 16) given wheat grass juice tablets for a year: packed cell requirement was 288.06 g/kg/year before and 301.25 after (p=0.054), with no adverse effects. The authors concluded that wheatgrass was not effective in reducing transfusion requirement. It is the null counterpart to the positive self-controlled pilot.